Mon.Feb 13, 2023

article thumbnail

ASHP President Urges Biden Administration to Utilize Pharmacists as Care Providers in Opioid Epidemic

Drug Topics

The letter outlined 7 steps that the Biden administration can take without the need for additional legislation.

187
187
article thumbnail

12 supplements to lower your blood pressure

The Checkup by Singlecare

Lots of people love the idea of taking something natural to improve their health. For example, the idea of taking a supplement that could improve their blood pressure and reduce their chances of heart attack or cardiovascular disease may be very appealing. But how effective–and safe–is this strategy? Before you decide to start taking any supplements for their alleged antihypertensive effects, it’s important to understand what those supplements can and can’t do.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Technology Trends to Prevent Prescription Errors

Drug Topics

Technology can streamline—and make safer—processes like medication reconciliation.

201
201
article thumbnail

Sun Pharma recalls at least 34,000 bottles of generic drug

Pharmafile

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, from the US market. The drug is used for treating high blood pressure, angina and some types of irregular heartbeat. This recall follows the FDA’s Enforcement Report, which saw “failed impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

FDA 115
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New Year Begins With Hikes in Drug Prices

Drug Topics

The list prices of 450 medications have increased 5% overall, and more price hikes are expected.

187
187
article thumbnail

Brian Fox is bringing ‘fresh eyes’ to ad agency Klick

PharmaVoice

Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

105
105

More Trending

article thumbnail

Survey: Nearly 3 in 5 teen girls felt persistently sad or hopeless in 2021

STAT

Teen girls reported record levels of violence, sadness, and thoughts of suicide in 2021, experiencing distress at twice the rate of teen boys, according to new federal data released Monday. The nearly 3 in 5 teen girls who felt persistently sad or hopeless in 2021 was a 60% increase compared to a decade earlier.

102
102
article thumbnail

Analytical platform could advance mRNA medicine QC

European Pharmaceutical Review

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines. The method is an important innovation for quality control ( QC) in production lines. The platform can elucidate mRNA sequences while quantifying ‘capping’ at one end of the molecule and the integrity of the tail on the other, all vital in mRNA pharmaceuticals.

article thumbnail

Patients still have no protection against surprise ambulance bills. And there’s no solution in sight

STAT

One night in November 2021, 11 weeks into her pregnancy, Carolyn Provine started bleeding — a lot. When she passed out, her wife and mother-in-law called an ambulance and drove 21 miles to the hospital for an emergency surgery. But the hemorrhaging, and miscarriage, no longer were Provine’s only concerns. “My first thought was, ‘Wait, is there some way for me not to take an ambulance?

Hospitals 102
article thumbnail

Weight loss jabs to be sold via high street chemists in England

The Guardian - Pharmaceutical Industry

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy Weekly weight-loss jabs that are popular with celebrities will soon be made available through high street chemists in England, despite controversy over their use. Many people struggle to tackle obesity through diet and exercise alone as they often find they regain the weight that they lose.

100
100
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Opinion: ChatGPT-assisted diagnosis: Is the future suddenly here?

STAT

The notion that people will regularly use computers to diagnose their own illnesses has been discussed for decades. Of course, millions of people try to do that today, consulting Dr. Google , though often with little success. Given the low quality of many online health sources, such searches may even be harmful. Some governments have even launched “ Don’t Google It ” campaigns to urge people not to use the internet for health concerns.

100
100
article thumbnail

How do I know if there is a copay card for my Rx?

The Checkup by Singlecare

Your healthcare provider prescribed you a brand-name medication. But, when you head to the pharmacy to pick it up, you’re shocked by its high price—and that’s with insurance. It’s a newer drug with no generic available, and even though you need it to manage a chronic health condition, there’s no way you’ll be able to afford it regularly. If you have to take an expensive prescription medication like Ozempic for Type 2 diabetes , Enbrel for rheumatoid arthritis , or Biktarvy for HIV , there’s good

article thumbnail

‘It is a balance’: Scientists grapple with ethics of cutting-edge stem cell research

STAT

SAN DIEGO — When biologist Alysson Muotri started tinkering with tiny balls of nerve cells in the lab more than a decade ago, his goal was simply to understand early brain development and neurological disease. He didn’t realize he was stumbling into an ethical minefield. His University of California, San Diego team found that when human stem cells were grown into so-called brain organoids in the lab, these tiny 3D structures produced regular waves of electrical activity that resemb

100
100
article thumbnail

Bridging the Health Equity Gap in Clinical Development

PharmExec

The COVID-19 pandemic has exposed global health inequities and is driving life sciences companies to establish strategies and better leverage data to address systemic causes and improve equity in access to healthcare innovations, particularly in clinical trials.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Could a swallowable, quarter-sized device make diagnosing GI diseases less unpleasant?

STAT

Diagnosing gastrointestinal disorders is an uncomfortable process. It might involve sticking a long tube with a camera attached down a patient’s throat, or inserting a small catheter through a patient’s nostril. A team of researchers from the Massachusetts Institute of Technology, the California Institute of Technology, and New York University, looking to explore more comfortable options, has designed an ingestible device that doctors can monitor as it moves through the GI tract.

98
article thumbnail

The Impact of AmazonSmile Ending

BuzzRx

Like many others, I was surprised to read that on February 20, 2023, Amazon will end its AmazonSmile program, which has raised close to half a billion dollars for charities in the last 10 years. The program worked by allowing customers to select a registered organization to support. When customers shopped through the program’s site www.smile.amazon.com , 0.5% of their purchases were donated to their chosen charity.

article thumbnail

Sen. Tammy Baldwin criticizes Ascension’s for-profit investment activities, requests returns and fees info

STAT

WASHINGTON — Sen. Tammy Baldwin on Monday blasted Ascension for service cuts at hospitals in Wisconsin and questioned whether returns from the Catholic health system’s for-profit investments are actually being used to help patients. Baldwin wrote a letter addressed to Ascension that cites STAT reporting about the extent of Ascension’s more than $1 billion in private equity investments alongside TowerBrook Capital Partners, including Ascension’s relationship with

article thumbnail

Teva to pay Florida $6.73M to settle state’s price fixing claims

Drug Store News

Teva will pay Florida $6.73 million, and the state will dismiss all of its claims against the company and its affiliates once payment has been made.

105
105
article thumbnail

Watch: Blockbuster drug Humira has new competition. Here’s why that matters

STAT

Humira has been the world’s best-selling medicine since it arrived on the market in 2002. Now, it is finally getting competition with the release of Amgen’s biosimilar drug, Amjevita. Humira’s main patent expired in 2016, but a byzantine patent saga has kept other drugmakers from offering their own version of the monoclonal antibody used to treat conditions such as rheumatoid arthritis and Crohn’s disease.

98
article thumbnail

Pfizer and BioNTech mRNA shingles vaccine study begins

European Pharmaceutical Review

Pfizer Inc. and BioNTech SE have announced the start of a Phase I/II trial for the companies’ mRNA vaccines for shingles (Herpes Zoster), for which there is no currently approved vaccine. Without vaccination, about half of the people who live to age 85 are expected to develop shingles, stated BioNTech. Both the incidence and severity of shingles rise with age, the company acknowledged.

article thumbnail

Opinion: How you can inspire your clinicians to reduce health-care-generated climate change

STAT

Almost everyone is a patient at some time. And even if the interaction with a doctor or nurse or other clinician is brief, it’s an opportunity to do something to fight climate change. The health care sector is responsible for 8.5% of all greenhouse gas emissions in the United States. To be sure, some of that comes from the amount of energy hospitals consume 24/7.

article thumbnail

Novel prostate cancer screening test found to be highly accurate

Hospital Pharmacy Europe

A novel prostate cancer screening test which incorporates PSA values and five chromosome conformations has an accuracy of 94% A UK research team have examined the value of a a novel prostate cancer (PaC) screening test based on measurement of five chromosome conformations and together with the prostate specific antigen (PSA) test, showed that the test has a high degree of accuracy for detecting the cancer.

article thumbnail

STAT+: In another pharma shakeup, Sanofi loses top executive known for overhauling R&D

STAT

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche. Prior to that, he was the CEO of the Sanford-Burnham Medical Research Institute in La Jolla, Calif., and a leading researcher in cell biology.

98
article thumbnail

CMS, insurers clash over whether Medicare Advantage is going to be cut in proposed rule

Fierce Healthcare

CMS, insurers clash over whether Medicare Advantage is going to be cut in proposed rule rking Mon, 02/13/2023 - 14:25

Insurance 115
article thumbnail

STAT+: Pharmalittle: Sanofi R&D head unexpectedly steps down; U.K. tax rate criticized after AstraZeneca locates plant in Ireland

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So we are trying to nudge it in a good direction by quaffing a few cups of stimulation.

article thumbnail

Black History Month: Celebrating Influential African American Pharmacists & Industry Trailblazers

Digital Pharmacist

To celebrate Black History Month, join us in honoring notable and courageous African American pharmacists and industry trailblazers. These influential leaders broke societal barriers through the years and paved the way for future generations of African American pharmacists and pharmacy owners. James McCune Smith ( 1813-1865) James McCune Smith was born into slavery in Manhattan until the Emancipation Act of New York set him free at the age of 14.

article thumbnail

Watch: Blockbuster drug Humira has new competition. Here’s why that matters

STAT

Humira has been the world’s best-selling medicine since it arrived on the market in 2002. Now, it is finally getting competition with the release of Amgen’s biosimilar drug, Amjevita. Humira’s main patent expired in 2016, but a byzantine patent saga has kept other drugmakers from offering their own version of the monoclonal antibody used to treat conditions such as rheumatoid arthritis and Crohn’s disease.

97
article thumbnail

Abrocitinib Approved for Adolescent Atopic Dermatitis

Drug Topics

The FDA approved a supplemental NDA for abrocitinib (Cibinqo) for adolescents with atopic dermatitis.

FDA 98
article thumbnail

Carol’s Daughter targets hair damage repair with pH-balancing formulas

Drug Store News

The Born To Repair (& Made To Care) collection features products formulated to help fight a year of visible damage in just one use, the company said.

98
article thumbnail

Providers want more from CMS on prior authorization reform after proposed changes

Fierce Healthcare

Providers want more from CMS on prior authorization reform after proposed changes rking Mon, 02/13/2023 - 17:36

105
105
article thumbnail

Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup

Fierce Pharma

Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup kdunleavy Mon, 02/13/2023 - 10:19

94
article thumbnail

Price Transparency and Patient Advocacy

Drug Topics

Advocates are a valuable resource in helping patients navigate care costs.

98
article thumbnail

Halle Berry joins wellness venture Pendulum Therapeutics

Drug Store News

Actor, producer and director Halle Berry will elevate public awareness on the importance of metabolism and gut health.

98
article thumbnail

Scancell shares “highly encouraging” results from phase 1 COVID-19 vaccine trial

Pharmafile

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief executive officer, Lindy Durrant. The COVIDITY study was run at the University of Cape Town Lung Institute in South Africa, and assessed both the safety and immune response of two candidates, SCOV1 and SCOV2. Both vaccine candidates were tested in unvaccinated patients and as boosters in volunteers who had already been vaccinated or who had previously been infected w